Correction: PIK3CA Genotype and a PIK3CA Mutation-Related Gene Signature and Response to Everolimus and Letrozole in Estrogen Receptor Positive Breast Cancer.
[This corrects the article DOI: 10.1371/journal.pone.0053292.].
Main Authors: | Sherene Loi, Stefan Michiels, Jose Baselga, John M S Bartlett, Sandeep K Singhal, Vicky S Sabine, Andrew H Sims, Tarek Sahmoud, J Michael Dixon, Martine J Piccart, Christos Sotiriou |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2019-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC6478332?pdf=render |
Similar Items
-
PIK3CA genotype and a PIK3CA mutation-related gene signature and response to everolimus and letrozole in estrogen receptor positive breast cancer.
by: Sherene Loi, et al.
Published: (2013-01-01) -
PIK3CA in colorectal cancer
by: Gieri eCathomas
Published: (2014-03-01) -
Alpelisib plus fulvestrant in PIK3CA-Altered and PIK3CA-wild-type estrogen receptor–positive advanced breast cancer: A phase 1b clinical trial
by: Juric, D, et al.
Published: (2018) -
Mutations in <it>PIK3CA </it>are infrequent in neuroblastoma
by: Mazanek Pavel, et al.
Published: (2006-07-01) -
Mutations of <it>PIK3CA </it>in gastric adenocarcinoma
by: So Samuel, et al.
Published: (2005-03-01)